BMS 6081 (Metaglip 2.5 mg / 250 mg)
Generic Name: glipizide/metformin
Pill with imprint BMS 6081 is Pink, Elliptical / Oval and has been identified as Metaglip 2.5 mg / 250 mg. It is supplied by Bristol-Myers Squibb.
Metaglip is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. Risk cannot be ruled out during pregnancy. Metaglip 2.5 mg / 250 mg is not a controlled substance under the Controlled Substance Act (CSA).
Images for BMS 6081
More about Metaglip (glipizide / metformin)
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- En Español
- 0 Reviews – Add your own review/rating
- Drug class: antidiabetic combinations
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.